FDA Inspection 795363 — Theravance Biopharma US, Inc.
The FDA completed an inspection of Theravance Biopharma US, Inc. on Aug 27, 2012 in South San Francisco, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 27, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- South San Francisco, CA (United States)
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)